W STRATEGIES, LLC

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · $20,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Medicare/Medicaid

Monitored Public Law 119-21: One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem